← Leaderboards
Thomas Vancott
Advanced Bioscience Laboratories, Inc.
$47,641,448
Attributed
$47,641,448
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.9M · FY2011–24$20M$15M$10M$5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$47,641,448 · 3
By mechanism
N01$46,655,042 · 3
N02$986,406 · 1
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- James Richardson$33,534,082
- Timothy Fouts$52,990,932
- Fred Mack$9,334,595
- Tim Fouts$2,183,383
- Phillip Ishikawa$23,550,479
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionContractsNational Institute Of Allergy And Infectious DiseaseInvestigational DrugsResearch Clinical TestingPreclinical TestingDocumentationProtocols DocumentationHiv VaccineResearch PersonnelImmunogenicityInvestigator-Initiated ResearchResearch StudyFlexibilityPreclinical DevelopmentHiv-1ContractorAids PreventionPamphletsModalityMicrobicideClinical TrialsQuality ControlQuality Assurance
Grant awards (36)
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines$60,889
N01 · FY2024 · AI · contact PI
Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s)$43,368
N01 · FY2024 · AI · contact PI
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines$265,381
N01 · FY2023 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS$346,256
N01 · FY2022 · AI · contact PI
PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN$2,509,960
N01 · FY2019 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities$1,821,904
N01 · FY2019 · AI · contact PI
Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s)$1,069,648
N01 · FY2019 · AI · contact PI
Essential Core Activities: NIAID Preclinical Development Support$385,578
N01 · FY2019 · AI · contact PI
Production of eCD4-IG protein$198,916
N01 · FY2019 · AI · contact PI
NIAID Preclinical Development Support - Production of Research Cell Lines$31,801
N01 · FY2019 · AI · contact PI
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines$1,887,453
N01 · FY2018 · AI · contact PI
NIAID Preclinical Development Support: Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s)$1,865,848
N01 · FY2018 · AI · contact PI
ESSENTIAL CORE ACTIVITIES, NIAID PRECLINICAL DEVELOPMENT SUPPORT$1,778,848
N01 · FY2018 · AI · contact PI
Essential Core Activities: NIAID Preclinical Development Support$351,370
N01 · FY2018 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT$251,381
N01 · FY2018 · AI · contact PI
NIAID Preclinical Development Support - Production of HIV-gp120 Proteins$249,939
N01 · FY2018 · AI · contact PI
ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT$1,737,288
N01 · FY2017 · AI · contact PI
Essential Core Activities: NIAID Preclinical Development Support$654,933
N01 · FY2017 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT$137,181
N01 · FY2017 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN$6,110,413
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS$5,072,696
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION FEASIBILITY EVALUATION OF TECHNOLOGY TO MODULATE PROTEIN EXPRESSION CELLULAR PATHWAYS$1,298,979
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN$374,069
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT$371,468
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION FEASIBILITY STUDY$322,862
N01 · FY2016 · AI · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$229,708
N01 · FY2016 · HL · contact PI
NIAID Preclinical Development Support - Production of Research Cell Lines$81,961
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN$6,431,145
N01 · FY2015 · AI · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$2,531,501
N01 · FY2015 · HL · contact PI
NIAID Preclinical Development Support - Production of Research Cell Lines$71,307
N01 · FY2015 · AI · contact PI
IGF::OT::IGF NIAID Preclinical Development Support - Regulatory Documentation for$68,910
N01 · FY2015 · AI · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$2,195,479
N01 · FY2014 · HL · contact PI
NIAID Preclinical Development Support - Production of Research Cell Lines$986,406
N02 · FY2014 · AI · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$2,189,062
N01 · FY2013 · HL · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$2,385,783
N01 · FY2012 · HL · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$1,271,757
N01 · FY2011 · HL · contact PI